跳至主要内容
临床试验/NCT06866639
NCT06866639尚未招募不适用

Cognitive Behavioural Therapy/Metacognitive Therapy for Low Self Esteem

University of Oslo1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
20
试验地点
1
主要终点
Rosenberg Self Esteem Scale

研究概览

简要总结

The goal for this clinical trial is to explore the effect of CBT/MCT on the treatment of low self esteem. 20 patients with low self-esteem will be selected and distributed into two either MCT or a CBT

We aim in this study to (1) evaluate the accessibility and effectiveness of MCT and CBT in treating low self-esteem, (2) investigate the patterns of change and the mechanisms of action involved during treatment, and (3) examine the impact of meta-cognitions and neuropsychologial processes in the treatment response and any relapse prevention of low self-esteem.

详细描述

The association between low self-esteem and psychiatric disorders indicates that low self-esteem is an important transdiagnostic construct. People who report having a low self-esteem seem to experience more mental health problems and a reduction in quality of life.

There have been a few trials considering the effect of Cognitive Behavioural Therapy (CBT) for low self-esteem, however, there are few randomized controlled studies. Recently, Meta Cognitive Therapy (MCT) has been introduced as a new, specific treatment for MDD, showing promising and lasting results. This treatment approach also has proven more effective than CBT for GAD or worry disorder. So far, no study has examined MCT for low self-esteem in a randomized controlled trial.

For the present clinical trial, 20 patients with low self-esteem will be selected and distributed into two treatment conditions. The first group (n=10) will be treated with MCT, whereas the second group (n = 10) will be treated with CBT. The patients will be assessed with different outcome measures at pre-treatment, at the end of treatment, and at six months follow up. In addition, they will also be assessed weekly using various measures.

We aim in this study to (1) evaluate the accessibility and effectiveness of MCT and CBT in treating low self-esteem, (2) investigate the patterns of change and the mechanisms of action involved during treatment, and (3) examine the impact of meta-cognitions and neuropsychologial processes in the treatment response and any relapse prevention of low self-esteem.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Signed written informed consent obtained prior to entry in the study.
  • •Scores below 15 on the Rosenberg Self-esteem Scale (RSE)
  • •18 years or older.

排除标准

  • •Bipolar type 1
  • •Current suicide intent
  • •Cluster A or cluster B personality disorder
  • •Substance dependence

研究组 & 干预措施

Cognitive behavioral therapy

Experimental

Cognitive behavioral therapy

干预措施: Cognitive behavioral therapy (Behavioral)

Metacognitive therapy

Experimental

Metacognitive therapy

干预措施: Metacognitive therapy (Behavioral)

结局指标

主要结局

Rosenberg Self Esteem Scale

时间窗: Baseline scores each week over two weeks before pre-treatment, pre-treatment, each session each week over 8 weeks , post-treatment (8 weeks), and six months follow up

The purpose of the 10 item RSE scale is to measure self-esteem.The scale ranges from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem

次要结局

  • GAD-7(Baseline scores each week over two weeks before pre-treatment, pre-treatment, each session each week over 8 weeks, post-treatment (8 weeks) and six months follow up)
  • PHQ-9(Baseline scores each week over two weeks before pre-treatment, pre-treatment, each session each week over 8 weeks , post-treatment (8 weeks) and six months follow up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Roger Hagen

Professor

University of Oslo

研究点 (1)

Loading locations...

相似试验